Sedano R - Search Results

1

Effectiveness of Tofacitinib for Hospitalized Patients with Acute Severe Ulcerative Colitis: Case Series.

Xiao Y, Benoit N, Sedano R, Jairath V, Narula N, McCurdy JD, Rosenfeld G, Afif W, Lakatos PL, Bessissow T. Xiao Y, et al. Among authors: sedano r. Dig Dis Sci. 2022 Nov;67(11):5213-5219. doi: 10.1007/s10620-022-07439-2. Epub 2022 Mar 4. Dig Dis Sci. 2022. PMID: 35244825

2

Intravenous Ustekinumab Reinduction Is Effective in Prior Biologic Failure Crohn's Disease Patients Already on Every-4-Week Dosing.

Sedano R, Guizzetti L, McDonald C, Jairath V. Sedano R, et al. Clin Gastroenterol Hepatol. 2021 Jul;19(7):1497-1498.e1. doi: 10.1016/j.cgh.2020.07.064. Epub 2020 Aug 4. Clin Gastroenterol Hepatol. 2021. PMID: 32763479

3

Clinical Trials of IL-12/IL-23 Inhibitors in Inflammatory Bowel Disease.

Almradi A, Hanzel J, Sedano R, Parker CE, Feagan BG, Ma C, Jairath V. Almradi A, et al. Among authors: sedano r. BioDrugs. 2020 Dec;34(6):713-721. doi: 10.1007/s40259-020-00451-w. BioDrugs. 2020. PMID: 33105016 Clinical Trial.

4

Tofacitinib Induced Long-term Clinical, Endoscopic, and Histological Remission as a 6th Line Agent in Medically Refractory Ulcerative Colitis.

Sedano R, Jairath V. Sedano R, et al. Inflamm Bowel Dis. 2021 Feb 16;27(3):e35-e36. doi: 10.1093/ibd/izaa296. Inflamm Bowel Dis. 2021. PMID: 33200783 No abstract available.

5

Drug-induced Lupus Associated With Vedolizumab in a Patient with Crohn's Disease.

Sedano R, Dhaliwal I, Ramsewak D, Jairath V. Sedano R, et al. Inflamm Bowel Dis. 2021 Mar 15;27(4):e47-e48. doi: 10.1093/ibd/izaa331. Inflamm Bowel Dis. 2021. PMID: 33319228 No abstract available.

6

High-Dose Rescue Tofacitinib Prevented Inpatient Colectomy in Acute Severe Ulcerative Colitis Refractory to Anti-TNF.

Sedano R, Jairath V. Sedano R, et al. Inflamm Bowel Dis. 2021 Apr 15;27(5):e59-e60. doi: 10.1093/ibd/izaa357. Inflamm Bowel Dis. 2021. PMID: 33484120 No abstract available.

7

Tofacitinib for the Treatment of Three Immune-mediated Conditions in One Patient: Ulcerative Colitis, Pyoderma Gangrenosum, and Alopecia Areata.

Sedano R, Jairath V. Sedano R, et al. Inflamm Bowel Dis. 2021 Apr 15;27(5):e65. doi: 10.1093/ibd/izab005. Inflamm Bowel Dis. 2021. PMID: 33484124 No abstract available.

8

An International Consensus to Standardize Integration of Histopathology in Ulcerative Colitis Clinical Trials.

Ma C, Sedano R, Almradi A, Vande Casteele N, Parker CE, Guizzetti L, Schaeffer DF, Riddell RH, Pai RK, Battat R, Sands BE, Rosty C, Dubinsky MC, Rieder F, Harpaz N, Abreu MT, Bryant RV, Lauwers GY, Kirsch R, Valasek MA, Crowley E, Sandborn WJ, Feagan BG, Pai RK, Jairath V. Ma C, et al. Among authors: sedano r. Gastroenterology. 2021 Jun;160(7):2291-2302. doi: 10.1053/j.gastro.2021.02.035. Epub 2021 Feb 19. Gastroenterology. 2021. PMID: 33610533 Free PMC article.

9

Editorial: standardising inclusion and outcome criteria for pouchitis-a fragile consensus perhaps but a first step in the right direction. Authors' reply.

Sedano R, Ma C, Jairath V. Sedano R, et al. Aliment Pharmacol Ther. 2021 May;53(10):1149-1150. doi: 10.1111/apt.16366. Aliment Pharmacol Ther. 2021. PMID: 33882168 No abstract available.

10

Impact of COVID-19 on Inflammatory Bowel Disease Clinical Trial Recruitment: A Global Survey of Principal Investigators.

Jairath V, Guizzetti L, Baker KA, Williamson LA, Sedano R, Thompson H, Ma C. Jairath V, et al. Among authors: sedano r. Inflamm Bowel Dis. 2021 Jul 27;27(8):e98. doi: 10.1093/ibd/izab111. Inflamm Bowel Dis. 2021. PMID: 33988238 Free PMC article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

48 results

Search Page